Cite
Smith C, McGrath M, Neller MA, et al. Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma. NPJ Precis Oncol. 2021;5(1):24doi: 10.1038/s41698-021-00162-7.
Smith, C., McGrath, M., Neller, M. A., Matthews, K. K., Crooks, P., Le Texier, L., Panizza, B., Porceddu, S., & Khanna, R. (2021). Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma. NPJ precision oncology, 5(1), 24. https://doi.org/10.1038/s41698-021-00162-7
Smith, Corey, et al. "Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma." NPJ precision oncology vol. 5,1 (2021): 24. doi: https://doi.org/10.1038/s41698-021-00162-7
Smith C, McGrath M, Neller MA, Matthews KK, Crooks P, Le Texier L, Panizza B, Porceddu S, Khanna R. Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma. NPJ Precis Oncol. 2021 Mar 19;5(1):24. doi: 10.1038/s41698-021-00162-7. PMID: 33742086; PMCID: PMC7979738.
Copy
Download .nbib